vidarabine phosphate has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lever, AM; Pignatelli, M; Scully, LJ; Thomas, HC; Yap, I | 1 |
| Hoofnagle, JH | 1 |
2 trial(s) available for vidarabine phosphate and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Topics: Acquired Immunodeficiency Syndrome; Arabinonucleotides; Carrier State; Clinical Trials as Topic; Hepatitis B; Hepatitis, Chronic; Homosexuality; Humans; Interferon Type I; Vidarabine; Vidarabine Phosphate | 1986 |
Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Topics: Acquired Immunodeficiency Syndrome; Arabinonucleotides; Clinical Trials as Topic; Follow-Up Studies; Hepatitis B; Hepatitis, Chronic; Homosexuality; Humans; Male; Time Factors; Vidarabine; Vidarabine Phosphate | 1986 |